Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 2,945 | 2,265 | 4,668 | 5,938 | 23 |
| Operating Income | -2,945 | -2,265 | -4,668 | -5,938 | -23 |
| Other Income | 2 | 4 | 0 | 0 | 0 |
| Pre-tax Income | -2,943 | -2,261 | -4,668 | -5,938 | -23 |
| Net Income Continuous | -2,943 | -2,261 | -4,668 | -5,938 | -23 |
| Net Income | $-2,943 | $-2,261 | $-4,668 | $-5,938 | $-23 |
| EPS Basic Total Ops | -0.32 | -0.54 | -1.04 | -1.43 | -0.01 |
| EPS Basic Continuous Ops | -0.32 | -0.55 | -1.04 | -1.43 | -0.01 |
| EPS Diluted Total Ops | -0.32 | -0.54 | -1.04 | -1.43 | -0.01 |
| EPS Diluted Continuous Ops | -0.32 | -0.55 | -1.04 | -1.43 | -0.01 |
| EBITDA(a) | $-2,945 | $-2,265 | $-4,668 | $-5,938 | $-23 |